Viscosupplementation Global Market Report 2025

Description

Viscosupplementation involves the injection of hyaluronic acid gel directly into the joint to alleviate friction during movement. Hyaluronic acid, naturally present in synovial fluid surrounding joints, aids in reducing friction during joint motion.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection methods. Single-injection viscosupplementation entails a direct injection of hyaluronic acid into the knee's diarthrodial joints, restoring the synovial fluid's rheological properties to generate anti-inflammatory and analgesic effects. Hyaluronic acid variations such as standard and stabilized forms, sourced from avian and non-avian origins, are used to address various osteoarthritic conditions such as knee, hip, and hand osteoarthritis. These treatments are administered across diverse healthcare settings, including hospitals, ambulatory surgical centers, among others.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends, and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.1 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to aging population, rising obesity rates, enhanced insurance coverage, growing awareness, patient preference, increased osteoarthritis cases.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to regulatory support, alternative payment models, increased healthcare expenditure, research and development, expansion of indications. Major trends in the forecast period include outcome-based payment models, patient education initiatives, biomarker development, gene therapy research, value-based care models.

The increasing prevalence of osteoarthritis is poised to be a significant driver for the viscosupplementation market in the foreseeable future. Osteoarthritis, a degenerative joint disease and a common form of arthritis, manifests in the breakdown of joints, particularly in areas such as the hips, knees, and hands. Viscosupplementation treatment, involving the direct injection of hyaluronic acid into bone joints, serves to alleviate pain and enhance smooth bone movement. According to the Centers for Disease Control and Prevention (CDC), an American public health service organization, a projected 78.4 million adults aged 18 years and older in the USA are expected to be afflicted by arthritis by the year 2040. This underscores the pivotal role of the rising prevalence of osteoarthritis in propelling the growth trajectory of the viscosupplementation market.

Anticipated growth in healthcare expenditure is set to foster the expansion of the viscosupplementation market in the coming years. Healthcare expenditure, denoting the total spending on healthcare costs, encompasses the financial outlay on healthcare-related goods and services within a specific healthcare system or economy. The surge in healthcare expenditure plays a pivotal role in advancing the broader adoption and increased accessibility of viscosupplementation. This support extends to various aspects, including research, training, infrastructure development, and coverage by healthcare plans, ultimately benefiting individuals grappling with joint-related issues. As of November 2022, the Canadian Institute for Health Information, a U.S.-based not-for-profit organization, reported a notable increase in healthcare expenditure to 0.8%, reaching $331 billion in 2022, compared to 7.6% in 2021. Consequently, the upward trajectory of healthcare expenditure emerges as a driving force behind the growth of the viscosupplementation market.

The viscosupplementation market is witnessing a surge in popularity driven by advancements in technology. Companies within this market are strategically embracing new technologies to maintain their competitive edge. In August 2021, Seikagaku Corporation, a prominent Japanese pharmaceutical firm, unveiled HyLink, an innovative viscosupplement designed for intra-articular single injection to address knee osteoarthritis. HyLink incorporates cross-linking technology, a method used to create a long-lasting cross-linked hyaluronate hydrogel that effectively persists in the joint cavity, establishing it as a durable treatment solution. This move reflects Seikagaku Corporation's commitment to staying at the forefront of technological developments within the viscosupplementation sector.

Leading companies in the viscosupplementation market are actively pursuing innovation to secure a competitive advantage. A notable example is Nuvo Pharmaceuticals Inc., a Canada-based pharmaceutical company, which, in January 2021, introduced NeoVisc+ 2 mL and NeoVisc ONE 4 mL in the Canadian market. These products are hyaluronic acid (HA) viscosupplements specifically designed to address pain relief and enhance joint functionality in patients with degenerative or mechanical arthropathy of the knee, commonly associated with osteoarthritis. The launch of NeoVisc+ 2 mL and NeoVisc ONE 4 mL underscores Nuvo Pharmaceuticals Inc.'s dedication to delivering cutting-edge treatment options for knee pain and osteoarthritis, contributing to the overall growth of the viscosupplementation market in Canada.

In December 2021, Avanos Medical Inc., a medical technology company based in the United States, successfully completed the acquisition of OrthogenRx Inc. for a total transaction value of $160 million. This strategic move significantly expanded, diversified, and enhanced Avanos Medical Inc.'s chronic pain product portfolio, specifically by incorporating treatment options for individuals with knee osteoarthritis. The acquisition was strategically aligned with the company's objective to fortify its partnerships with healthcare providers on a global scale, particularly in the realm of musculoskeletal pain treatment. OrthogenRx Inc., a U.S.-based medical device company with expertise in viscosupplementation therapies for knee osteoarthritis, played a pivotal role in reinforcing Avanos Medical Inc.'s position in this therapeutic space.

Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group

North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
2) By Source: Avian Origin; Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Zimmer Biomet; Johnson & Johnson Services Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23832

1. Executive Summary

2. Viscosupplementation Market Characteristics

3. Viscosupplementation Market Trends And Strategies

4. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Viscosupplementation Growth Analysis And Strategic Analysis Framework

5.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Viscosupplementation Market Growth Rate Analysis
5.4. Global Viscosupplementation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Viscosupplementation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Viscosupplementation Total Addressable Market (TAM)

6. Viscosupplementation Market Segmentation

6.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Injection Viscosupplementation
Three Injection Viscosupplementation
Five Injection Viscosupplementation
6.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Avian Origin
Non-Avian Origin
6.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Hyaluronic Acid
Stabilized Hyaluronic Acid
6.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
6.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Other End-Users
6.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyaluronic Acid-Based Products
Non-Hyaluronic Acid Products
6.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyaluronic Acid-Based Products
Combination Products
6.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyaluronic Acid-Based Products
Combination Products

7. Viscosupplementation Market Regional And Country Analysis

7.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viscosupplementation Market

8.1. Asia-Pacific Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viscosupplementation Market

9.1. China Viscosupplementation Market Overview
9.2. China Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viscosupplementation Market

10.1. India Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viscosupplementation Market

11.1. Japan Viscosupplementation Market Overview
11.2. Japan Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viscosupplementation Market

12.1. Australia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viscosupplementation Market

13.1. Indonesia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viscosupplementation Market

14.1. South Korea Viscosupplementation Market Overview
14.2. South Korea Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viscosupplementation Market

15.1. Western Europe Viscosupplementation Market Overview
15.2. Western Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viscosupplementation Market

16.1. UK Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viscosupplementation Market

17.1. Germany Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viscosupplementation Market

18.1. France Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viscosupplementation Market

19.1. Italy Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viscosupplementation Market

20.1. Spain Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viscosupplementation Market

21.1. Eastern Europe Viscosupplementation Market Overview
21.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viscosupplementation Market

22.1. Russia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viscosupplementation Market

23.1. North America Viscosupplementation Market Overview
23.2. North America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viscosupplementation Market

24.1. USA Viscosupplementation Market Overview
24.2. USA Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viscosupplementation Market

25.1. Canada Viscosupplementation Market Overview
25.2. Canada Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viscosupplementation Market

26.1. South America Viscosupplementation Market Overview
26.2. South America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viscosupplementation Market

27.1. Brazil Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viscosupplementation Market

28.1. Middle East Viscosupplementation Market Overview
28.2. Middle East Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viscosupplementation Market

29.1. Africa Viscosupplementation Market Overview
29.2. Africa Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viscosupplementation Market Competitive Landscape And Company Profiles

30.1. Viscosupplementation Market Competitive Landscape
30.2. Viscosupplementation Market Company Profiles
- 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Viscosupplementation Market Other Major And Innovative Companies

31.1. Aptissen S.A.
31.2. Smith & Nephew Plc.
31.3. Flexion Therapeutics Inc.
31.4. Regen Lab SA
31.5. OrthogenRx Inc.
31.6. Fidia Farmaceutici S.P.A
31.7. Ferring Pharmaceuticals
31.8. Laboratoires VIVACY
31.9. Allergan
31.10. Hyalgan
31.11. Synvisc
31.12. Euflexxa
31.13. Sanofi S.A.
31.14. Wellchem Pharmaceuticals Pte Ltd.
31.15. SingHealth Group

32. Global Viscosupplementation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Market

34. Recent Developments In The Viscosupplementation Market

35. Viscosupplementation Market High Potential Countries, Segments and Strategies

35.1 Viscosupplementation Market In 2029 - Countries Offering Most New Opportunities
35.2 Viscosupplementation Market In 2029 - Segments Offering Most New Opportunities
35.3 Viscosupplementation Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer